Background: In several malignancies extracapsular lymph node involvement (ECLNI) identifies a subgroup of patients with worse prognosis but no data are available on its significance in pancreatic ductal adenocarcinoma (PDAC). The aim of our study was to assess the prognostic relevance of ECLNI in resectable PDAC.
Methods: A retrospective analysis was performed of 137 consecutive pancreatic resections for PDAC. Two investigators blinded for survival data systematically reviewed all pathological data. Survival curves were estimated using the Kaplan-Meier method. Multivariable Cox regression models were used to identify predictors of disease-free survival (DFS) and overall survival (OS). The median follow-up after surgery was 19 months.
Results: ECLNI was identified in 59 of 99 node-positive patients. The median DFS in patients with ECLNI vs. intracapsular LNI (ICLNI) was 6.8 vs. 12.0 months, respectively (P=.027). The median OS in patients with ECLNI vs. ICLNI was 16.1 and 21.8 months, respectively (P=.098). On multivariable analysis extracapsular lymph node ratio (ECLNR) was identified as an independent predictor of OS (P=.003). In patients with ECLNI, both OS and DFS were improved after adjuvant chemoradiation compared with those who did not receive adjuvant treatment (P=.01).
Conclusions: Extracapsular lymph node ratio is an independent predictor of survival in patients with PDAC. Patients with ECLNI from pancreatic cancer seem to benefit from adjuvant chemoradiation but not from chemotherapy alone.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1245/s10434-009-0627-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Presentation and Management of Silicone Lymphadenopathy: A Single Institutional Retrospective Cohort Study.
Aesthetic Plast Surg
January 2025
Division of Plastic and Reconstructive Surgery, DeWitt Daughtry Family Department of Surgery, Miami, FL, USA.
Introduction: Silicone Lymphadenopathy (SL) is a complication of breast implants that involves migration of silicone to nearby soft tissue/lymph nodes. Data on its clinical features and management is scarce. We aimed to identify the clinical presentation and management of SL.
View Article and Find Full Text PDFPatterns of recurrence following radiation and ADT for pathologic lymph node positive prostate cancer: A multi-institutional study.
Pract Radiat Oncol
December 2024
Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH.
Background And Objective: We evaluate prognostic factors and patterns of recurrence in patients who received RT ± androgen deprivation therapy (ADT) for pathologic node-positive (pN1) prostate cancer (PCa) in a multi-institutional cohort.
Methods: Data from patients with pN1 PCa and received RT with short term (ST, ≤6 mo) or long term (LT, >6 mo) ADT were obtained from 4 academic institutions. Biochemical progression free survival (bPFS) and distant metastasis free survival (DMFS) were evaluated.
Is conservative treatment always safe in unifocal clinically T1a/node-negative papillary thyroid carcinoma?
World J Surg
January 2025
UOC Chirurgia Endocrina e Metabolica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Article Synopsis
- Management of unifocal node-negative papillary thyroid carcinoma (PTMC) under 1 cm is debated, with nonsurgical options like active surveillance possibly insufficient for assessing aggressive traits or hidden lymph node metastases.
- Out of 4216 thyroidectomies for malignancy, 203 patients underwent thyroid lobectomy plus neck dissection, revealing that 37.4% had positive lymph node involvement and biological aggressive features were found in a significant portion of patients.
- The study identified younger age and multifocality as significant risk factors for hidden lymph node metastases, emphasizing that while PTMC is often seen as low-risk, some patients may exhibit aggressive characteristics, making cautious nonsurgical management essential to avoid undertreatment.
Malignant struma ovarii in pregnancy: A case report.
Gynecol Oncol Rep
December 2024
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, McMaster University, 699 Concession Street, Hamilton, Ontario L8V 5C2, Canada.
Article Synopsis
- * A 27-year-old pregnant patient was diagnosed with malignant struma ovarii after emergency surgery for ovarian torsion revealed a 3 cm tumor, initially monitored during pregnancy due to the lack of high-risk features.
- * After giving birth, the patient had a recurrence treated with extensive surgeries and radioactive iodine therapy, and she remained disease-free three years post-diagnosis, highlighting the need for personalized treatment approaches for MSO.
Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas.
Br J Cancer
November 2024
Technical University of Munich, TUM School of Medicine and Health, Institute of General and Surgical Pathology, Munich, Germany.
Background: We aimed to validate the prognostic significance of tumor budding (TB) in p16-positive oropharyngeal squamous cell carcinomas (OPSCC).
Methods: We analyzed digitized H&E-stained slides from a multicenter cohort of five large university centers consisting of n = 275 cases of p16-positive OPSCC. We evaluated TB along with other histological parameters (morphology, tumor-stroma-ratio, lymphovascular invasion (LVI), perineural invasion) and calculated survival outcomes using both univariate and multivariate analyses.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!